Health aid pays for life-saving medicines, products, and services in the poorest countries in the world. Funding for such uses needs to be smooth and uninterrupted. But when fraud is detected, funds are subject to sudden stops and starts—the result of a sequence of events set off by the scandal cycle in health aid. We examine this idea in a new CGD policy paper.
CGD Policy Blogs
This is a joint post with Edward Collins.
Can we assess ag aid quality? The short answer: sort of.
For at least a decade, aid effectiveness has been in the spotlight because of concerns that, in some cases, aid may do more harm than good and, more recently, because of growing budget pressures. In 2005, donor and recipient countries agreed on a set of principles for more effective aid and a process to monitor implementation of those principles with the Paris Declaration on Aid Effectiveness. Based on these principals, and with the objective to provide an independent evaluation of donor performance, Nancy Birdsall, Homi Kharas, and colleagues launched a joint Center for Global Development and Brookings Institution project to assess the Quality of Official Development Assistance, QuODA for short. Now in its second edition, this project motivated CGD colleagues Amanda Glassman and Denizhan Duran to apply the QuODA methodology to health aid and now, we’ve done the same thing for agricultural aid.